Publications by authors named "Beate Rautenberg"

Claim this Profile
D
Development and Validation of Integrated Palliative Care Outcome Scale Short Form for Efficient Specialist Palliative Care Screening in Oncology (ScreeningPALL): A Cross-Sectional Study.
Evelyn Müller, Michael J Müller, Paul Sölder, Beate Rautenberg, Maryam En-Nosse

J Palliat Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer: The REACT Randomized Clinical Trial.
R Charles Coombes, Holly Tovey, Lucy Kilburn, Janine Mansi, Carlo Palmieri, Beate Rautenberg

JAMA Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of modified short-term fasting and its combination with a fasting supportive diet during chemotherapy on the incidence and severity of chemotherapy-induced toxicities in cancer patients - a controlled cross-over pilot study.
Stefanie Zorn, Janine Ehret, Rebecca Schäuble, Beate Rautenberg, Gabriele Ihorst

BMC Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM/CD3 T-cell engager (BiTE®) antibody construct, in patients with refractory solid tumors.
Maxim Kebenko, Marie-Elisabeth Goebeler, Martin Wolf, Annette Hasenburg, Ruth Seggewiss-Bernhardt, Beate Rautenberg

Oncoimmunology· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase III, open label, randomized multicenter controlled trial of oral versus intravenous treosulfan in heavily pretreated recurrent ovarian cancer: a study of the North-Eastern German Society of Gynecological Oncology (NOGGO).
Jalid Sehouli, Oliver Tomè, Desislava Dimitrova, Oumar Camara, Ingo Bernhard Runnebaum, Beate Rautenberg

J Cancer Res Clin Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetic targeting of pegylated liposomal doxorubicin: a new approach to reduce toxicity during chemotherapy (CARL-trial).
Jürgen Eckes, Oliver Schmah, Jan W Siebers, Ursula Groh, Stefan Zschiedrich, Beate Rautenberg

BMC Cancer· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis